Fusion Antibodies PLC Sustainability Reports
Fusion Antibodies PLC operates as a contract research organization (CRO) that provides pre-clinical antibody discovery, engineering, and expression services. The company specializes in antibody humanization, cell line development, and antigen expression to help speed up drug development for pharmaceutical, biotech, and diagnostic clients.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
ISIN: GB00BDQZGK16
8 reports from 2018 to 2025